HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James R Sowers Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

1/2021Mineralocorticoid receptors in the pathogenesis of insulin resistance and related disorders: from basic studies to clinical disease.
1/2019Utility of obesity and metabolic dyslipidemia (a non-insulin based determinate of the metabolic syndrome and insulin resistance) in predicting arterial stiffness.
11/2014Overnutrition, mTOR signaling, and cardiovascular diseases.
6/2014Fructose and uric acid: is there a role in endothelial function?
1/2014Estrogen and mitochondria function in cardiorenal metabolic syndrome.
10/2012Insulin resistance and heart failure: molecular mechanisms.
1/2011The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease.
11/2010Resistant hypertension in office practice: a clinical approach.
11/2010Retinal redox stress and remodeling in cardiometabolic syndrome and diabetes.
10/2010Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James R Sowers Research Topics

Disease

85Insulin Resistance
01/2022 - 02/2002
80Hypertension (High Blood Pressure)
11/2021 - 06/2002
59Obesity
01/2022 - 11/2004
55Fibrosis (Cirrhosis)
10/2021 - 01/2006
46Inflammation (Inflammations)
01/2022 - 02/2003
37Type 2 Diabetes Mellitus (MODY)
12/2022 - 07/2002
37Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 06/2002
28Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 02/2002
25Proteinuria
01/2017 - 02/2002
18Hypertrophy
12/2017 - 01/2006
14Kidney Diseases (Kidney Disease)
01/2019 - 04/2008
12Chronic Renal Insufficiency
11/2021 - 03/2005
11Albuminuria
01/2021 - 06/2004
11Dyslipidemias (Dyslipidemia)
01/2021 - 11/2002
10Hyperglycemia
08/2014 - 07/2002
9Overnutrition
01/2017 - 01/2011
9Weight Loss (Weight Reduction)
10/2015 - 10/2003
7Heart Failure
12/2022 - 07/2009
7Vascular Remodeling
01/2022 - 09/2009
7Diabetes Mellitus
11/2021 - 02/2002
7Mitochondrial Diseases (Mitochondrial Disease)
01/2018 - 02/2008
6Body Weight (Weight, Body)
01/2022 - 08/2010
5Hyperaldosteronism (Conn Syndrome)
01/2019 - 06/2004
5Left Ventricular Dysfunction
01/2018 - 07/2007
5Cardiomegaly (Heart Hypertrophy)
10/2017 - 05/2007
5Non-alcoholic Fatty Liver Disease
01/2016 - 09/2008
5Hyperinsulinism (Hyperinsulinemia)
03/2013 - 01/2004
5Glucose Intolerance
06/2009 - 09/2006
5Atherosclerosis
05/2009 - 01/2004
4Diabetic Cardiomyopathies
01/2018 - 08/2003
4Neoplasms (Cancer)
11/2016 - 03/2005
4Weight Gain
07/2015 - 04/2010
4Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
03/2015 - 01/2006
4Stroke (Strokes)
02/2013 - 06/2003
3Cardiomyopathies (Cardiomyopathy)
10/2021 - 01/2011
3Metabolic Diseases (Metabolic Disease)
10/2018 - 01/2011
3Chronic Kidney Failure (Chronic Renal Failure)
01/2017 - 04/2004

Drug/Important Bio-Agent (IBA)

67Insulin (Novolin)FDA Link
01/2022 - 06/2002
36Glucose (Dextrose)FDA LinkGeneric
10/2021 - 07/2002
30AldosteroneIBA
01/2022 - 02/2003
28Angiotensin IIIBA
01/2021 - 06/2002
27Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2022 - 06/2008
22Reactive Oxygen Species (Oxygen Radicals)IBA
06/2015 - 11/2006
20ReninIBA
06/2013 - 12/2006
18NADPH Oxidases (NAD(P)H oxidase)IBA
06/2012 - 08/2003
16Antihypertensive Agents (Antihypertensives)IBA
12/2013 - 01/2004
15Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2007
14Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021 - 02/2003
14LipidsIBA
01/2020 - 02/2003
11CytokinesIBA
11/2021 - 01/2004
11NebivololFDA Link
09/2012 - 01/2009
10CarbohydratesIBA
01/2022 - 04/2008
10Spironolactone (Aldactone)FDA LinkGeneric
01/2022 - 07/2008
10Angiotensin Receptor AntagonistsIBA
10/2021 - 12/2008
10Oxidants (Oxidizing Agents)IBA
01/2020 - 03/2010
9Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2021 - 02/2002
9Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 02/2003
9FructoseIBA
08/2017 - 10/2013
93-nitrotyrosineIBA
12/2013 - 02/2007
8AngiotensinsIBA
04/2014 - 01/2011
8Hydrochlorothiazide (Esidrix)FDA LinkGeneric
07/2011 - 10/2005
7Type 1 Angiotensin ReceptorIBA
01/2017 - 12/2006
7Uric Acid (Urate)IBA
01/2017 - 06/2014
7AdipokinesIBA
12/2016 - 12/2005
7SaltsIBA
04/2014 - 06/2004
6Nitric Oxide Synthase (NO Synthase)IBA
01/2020 - 01/2009
6CholesterolIBA
01/2016 - 11/2002
6Hormones (Hormone)IBA
08/2014 - 06/2004
5Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 01/2008
5SodiumIBA
10/2019 - 01/2004
5CollagenIBA
01/2018 - 11/2007
5CalciumIBA
01/2018 - 03/2005
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2016 - 01/2004
5Metformin (Glucophage)FDA LinkGeneric
10/2015 - 07/2002
5Rosuvastatin Calcium (Crestor)FDA Link
03/2015 - 05/2007
5Valsartan (Vals)FDA Link
02/2013 - 02/2005
5Oxidoreductases (Dehydrogenase)IBA
09/2011 - 12/2007
5DiureticsIBA
11/2010 - 09/2004
5IrbesartanFDA LinkGeneric
03/2010 - 10/2005
4Epithelial Sodium ChannelsIBA
11/2021 - 01/2017
4Calcium Channel Blockers (Blockers, Calcium Channel)IBA
10/2021 - 01/2005
4Low Density Lipoprotein Receptor-Related Protein-2IBA
01/2021 - 01/2010
4Hypoglycemic Agents (Hypoglycemics)IBA
01/2018 - 07/2002
4Phosphotransferases (Kinase)IBA
01/2017 - 03/2012
4MineralocorticoidsIBA
05/2015 - 01/2007
4Triglycerides (Triacylglycerol)IBA
03/2015 - 12/2003
4TOR Serine-Threonine KinasesIBA
11/2014 - 01/2011
4IncretinsIBA
08/2014 - 01/2008
4LeptinIBA
06/2014 - 01/2004
4AdiponectinIBA
06/2014 - 12/2005
4Oxygen (Dioxygen)IBA
10/2013 - 06/2003
4Serine (L-Serine)FDA Link
04/2013 - 01/2011
4aliskirenFDA Link
02/2013 - 11/2008
4Free RadicalsIBA
01/2011 - 06/2003
4ThiazolidinedionesIBA
08/2010 - 07/2002
3Mineralocorticoid Receptor AntagonistsIBA
01/2019 - 04/2010
3Amiloride (Midamor)FDA LinkGeneric
01/2018 - 01/2017

Therapy/Procedure

34Therapeutics
12/2022 - 06/2002
6Glycemic Control
01/2018 - 10/2003
5Bariatric Surgery
04/2013 - 04/2010